Skip to main content

Drug War Daily Digest – November 12, 2026

Submitted by Phillip Smith on (Issue #1242)
Consequences of Prohibition

DEA proposes sharply higher 2027 production quotas for MDMA, ibogaine and psilocybin and is reportedly challenging some medical marijuana businesses' applications for federal protections. Texas Democrats file legalization bills, 16 governors press Congress on cannabis banking, and the Duterte defense asks the ICC to drop two prosecution witnesses ahead of the November 30 trial.

After last week's election shock, the Lone Star State could be joining the marijuana legalization parade. (mpp.org)

Marijuana Policy

Texas Democrats File Legalization Bills as Leaders Preview Cannabis Cooperation for 2027. Tom Angell reports in Marijuana Moment that Rep. Joe Moody and Rep. John Bucy III have filed largely identical bills, HB 369 and HB 362, respectively, creating a licensed adult-use market under a Texas Regulation of Cannabis Act. In the upper chamber, Sen. Carol Alvarado has filed SB 237. HB 369 would let adults 21 and older possess up to two ounces (no more than 15 grams of concentrate) and grow up to 12 plants at home, tax transfers and sales, and divide the revenue among schools, veterans, drug treatment and local governments. SB 237 sets a higher 2.5-ounce possession limit, gives counties the power to ban cannabis businesses, and relies on licensing and application fees rather than new excise taxes.

Other filed bills would reduce penalties for concentrates (Moody's HB 667), allow medical access for conditions that cause menstrual cramps (Rep. Mihaela Plesa's HB 330), and bar cannabinoid testing for most state and local government employees and independent contractors (Bucy's HB 507). All the sponsors are Democrats; the session begins in January. Separately, Tom Angell reports that Lt. Gov.-elect Vikki Goodwin (D) wants THC regulation rather than a full ban; Rep. Wes Virdell (R-Kerrville), speaking to KXAN, says he and Democrats can align on age limits and product-quality rules and on ending felony penalties for THC products such as gummies and vape cartridges, and Gov.-elect Gina Hinojosa (D) wants voters to decide on legalization by referendum, which would require the legislature to place a constitutional amendment on the ballot.

NORML: Wisconsin and Pennsylvania Democrats Signal Legalization Pushes After Midterms. The marijuana reform advocacy group NORML reports that in Wisconsin, Gov.-elect David Crowley and Assembly Minority Leader Greta Neubauer, who is poised to become speaker, have publicly backed legalization after Democrats took control of both the state House and Senate. Neubauer said Democrats intend to legalize within one to two years, and Sen. Mark Spreitzer, the Democratic caucus chair, said he is "very optimistic." NORML cites a 2025 Marquette poll showing 67 percent support and notes that Wisconsin police made nearly 11,500 possession arrests last year, the third-highest total of any state. Under state law, a first marijuana-possession conviction can bring up to six months in jail and a $1,000 fine.

In Pennsylvania, Democrats will have single-party legislative control next year after flipping the Senate, which had removed legalization language Gov. Josh Shapiro put in budget proposals and left a House-passed bill stalled last year. NORML reports that House Speaker Joanna McClinton said in September that legislation would have a realistic pathway if Democrats flipped the Senate.

Sixteen Democratic Governors Urge Congress to Pass SAFE Banking. Marijuana Moment reports that 16 Democratic governors, led by Maryland's Wes Moore, who chairs the National Governors Association, sent a letter on Monday urging Congress to pass the SAFE Banking Act (S4942/HR9471). They say the bill would give state-legal marijuana businesses access to core banking services and protect banks that serve them, and that it respects state sovereignty. The signers are the governors of Colorado, Connecticut, Delaware, Illinois, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Mexico, New York, Oregon, Virginia, Washington and Wisconsin.

New Hampshire Democrats Discuss Legalization; North Carolina Speaker-Elect Says Decriminalization Is on Lawmakers' Minds. Democrats who will control both New Hampshire legislative chambers in 2027 and 2028 have marijuana legalization on their minds, Tom Angell reports in Marijuana Moment. Rep. Will Darby told WMUR he personally supports introducing adult-use legalization with state controls, but Republican Gov. Kelly Ayotte, who was reelected, strongly opposes it; Democrats appear to have won a two-thirds House majority but are not projected to reach two-thirds in the Senate, so overriding a veto would likely need Republican votes.

In North Carolina, Democratic House Speaker-elect Robert Reives identified decriminalization as a legislative priority Tuesday, according to WRAL as reported by Marijuana Moment. Gov. Josh Stein (D) supports broader legalization and convened a state commission to evaluate options, and the Senate under Republican leadership has previously passed medical cannabis bills several times only for House Republican leaders to block them.

Medical Marijuana

DEA Reportedly Challenging Some Medical Marijuana Businesses' Applications for Federal Protections; Missouri Warns Licensees on Interstate Commerce. Citing unnamed industry sources and the partial text of documents, Tom Angell reports in Marijuana Moment that DEA has sent orders to show cause to some medical marijuana businesses seeking federal registration under the rescheduling of state-licensed medical marijuana in California, Delaware, Illinois, North Dakota, Oregon and Washington, DC, following an earlier show-cause order in Minnesota. The orders reportedly argue that states that allow non-medical sales are out of compliance with the Controlled Substances Act's closed system and US treaty obligations. The orders argue that Illinois and Minnesota dual-license arrangements lack adequate safeguards against diversion; California and DC allow dispensing without a written physician certification; Illinois lets veterans qualify with VA records instead; and DC allows patient self-certification. The article does not say how many businesses received orders or whether any final denials have been issued, and full orders were not included in the linked report. The DC proceeding was originally reported by MJBizDaily. The Marijuana Moment report also notes that DEA reportedly approved more than 900 applicants across seven states last month.

Separately, Missouri's Division of Cannabis Regulation published guidance November 2 saying state law does not authorize import, export, or interstate commerce of regulated marijuana; licensees could obtain such authority through federal registration but cannot use it until Missouri updates its rules, and the division says rescheduling adds federal requirements on top of the state program rather than replacing it.

Kentucky Medical Cannabis Program Passes 30,000 Patients. Kentucky has approved medical cannabis cards for more than 30,000 people, Lt. Gov. Jacqueline Coleman announced at the weekly Team Kentucky update, according to WNKY-TV. The state reports 47 businesses operating, including 27 dispensaries; that represents more than half of its planned business build-out. Graham Abbott of Ganjapreneur also notes a dispute over Gov. Andy Beshear's executive order adding 15 qualifying conditions earlier this year: Rep. Jason Nemes challenged the governor's authority and called for prosecution of organizations or licensees that implemented it.

Massachusetts Senate Passes Veterans Medical Marijuana Provision 35–4. Marijuana Moment reports that the state Senate voted 35 to 4 on November 5, for an amended version of a House-passed supplemental budget bill that would let veterans become registered medical cannabis patients with official VA documentation of a debilitating condition, without a separate certification from a health care professional. The bill also expands the list of qualifying conditions to include PTSD, opioid use disorder, and conditions producing chronic pain. The bill history records Senate passage November 5. The chambers still needed to agree on a final version before sending it to Gov. Maura Healey, according to the November 6 report.

Senate Appropriators' Reports Address VA Marijuana Research, Psychedelics and Infused Foods. The Senate Appropriations Committee posted its fiscal 2027 bill text and reports Tuesday, and Tom Angell reports in Marijuana Moment on the language that touches drug policy. The Veterans Affairs report encourages VA to consider clinical research on medical marijuana and to study whether state medical marijuana programs relate to reduced veteran opioid use, and directs VA to brief Congress within 180 days of enactment on a plan to expand psychedelic research and prepare for FDA-approved psychedelic therapies. The FDA and Agriculture report encourages FDA to work with VA, the Defense Department and NIH on psychedelic clinical trials, voices concern about cannabinoid-infused foods because no cannabinoid is approved as a food additive and asks FDA to report within 90 days of enactment on enforcement coordination, and notes $12,996,000 for USDA's Hemp Production Program. The November 11 report did not identify a scheduled committee vote; the report language does not itself change law.

On Wednesday, Nov. 18, S3 Collective and Leaf411 hold a webinar, "Beyond the Laboratory: How Academic Cannabis Research Is Informing Policy and Practice," at 2:00pm ET on Zoom, and S3 Collective lists a meeting of the ASTM D37.11 Human Health Subcommittee at 12:00pm ET on WebEx.

Hemp

Congressional Researchers Report Overdue FDA Hemp Cannabinoid Lists. A Congressional Research Service legal sidebar dated October 28 notes that the FDA, which was required to publish within 90 days of enactment lists of cannabinoids a cannabis plant can naturally produce, THC-class cannabinoids and similar-effect cannabinoids, and more specificity on the term "container," had not done so as of October 28. Marijuana Moment reported November 9 that the deadline was February 10, making the agency about nine months late. The sidebar also confirms the schedule: a September law (Pub. L. 119-103) moved most of the hemp-definition changes, including the total-THC limit, from November 12 to December 11, while the exclusion of products containing cannabinoids not capable of being naturally produced by the plant was not delayed and took effect November 12.

Missouri Attorney General Sues Four Retailers Over THC Products Marketed as Hemp. Ganjapreneur reports that state Attorney General Catherine Hanaway (R) announced November 4 that her office is suing four retailers – Puffers Choice in Aurora, CBD Kratom Cannabis Dispensaries in Des Peres, Herb Depot in Independence and Token THC Dispensary in Rock Port – for allegedly selling products marketed as hemp that exceeded legal THC limits and so counted as marijuana under Missouri law, and that they presented themselves deceptively as state-legal dispensaries.

Criminal Justice

Virginia Republican Files Resolution to Investigate, Possibly Expel Indicted Sen. Louise Lucas. WJLA-TV reports that Sen. Bryce Reeves (R-Spotsylvania) pre-filed Senate Resolution 173, which would direct the Privileges and Elections Committee to investigate Sen. Louise Lucas, a Democrat, and asks members to consider expelling her. Lucas faces five federal charges: racketeering conspiracy, conspiracy to distribute and possess with intent to distribute marijuana, conspiracy to launder money, conspiracy to commit honest-services fraud, and maintaining a drug-involved premises. Lucas has denied the accusations and had not responded to the resolution when the article was updated on November 9. VPM reported November 12 that Gov. Abigail Spanberger (D) had declined further comment on Lucas's next steps before her upcoming court appearance. A federal court notice schedules Lucas's arraignment for November 16 in Newport News.

Extrajudicial Killings

House Refers Hegseth Impeachment Resolution to Judiciary Committee, 211-204. The House voted November 10 to send Rep. Thomas Massie's H.Res. 1655 to the Judiciary Committee, stalling floor consideration. The motion drew support from 210 Republicans and one independent; 203 Democrats and Massie opposed it. Eleven Democrats and seven Republicans did not vote. One of the eight proposed articles accuses Defense Secretary Pete Hegseth of unlawfully replacing maritime drug enforcement with military attacks that killed at least 221 people. It also alleges attacks on survivors and interference with military legal scrutiny. These are allegations in Massie's resolution. The other articles address Iran, Venezuela, Yemen and retaliation against Sen. Mark Kelly. House Democratic leader Hakeem Jeffries told ABC News November 8 that he was a "hard yes" on impeachment.

Duterte Defense Asks ICC to Drop Two Prosecution Witnesses. Janna Millenas reports for VERA Files that defense counsel Peter Haynes asked Trial Chamber III to order the prosecution to drop witnesses P-1334 and P-1348, arguing in a six-page filing that both were absent for nearly the entire period covered by Counts 2 and 3 and that their accounts rest on stories they heard, media and social media coverage and conjecture. The defense says P-1334 has no personal knowledge of how instructions were relayed through Ronald dela Rosa, and that P-1348 cannot speak from experience about alleged rewards and killing quotas. If the chamber retains them on the witness list, the defense takes no position on admitting their prior recorded testimony and asks that only parts about matters other than Duterte's own acts and conduct be admitted. The prosecution argues the testimony is relevant to the crimes' contextual elements. The November 10 report did not report a ruling on the motion. The trial is scheduled to open November 30; VERA Files earlier reported that the first block runs daily through December 18 and resumes January 11.

Philippine Truth Commission Releases Mother's Quota Suspicions and Calls for Investigation. In a November 10 release on its November 6 public session, the Philippine Truth Commission says Marissa Lazaro, whose son Christopher Lazaro, 20, was killed with Alberto Paragas, 32, in Marilao, Bulacan, on August 5, 2017, told the session she suspects police split the bodies of four friends between Marilao and neighboring Bocaue to meet quotas. She offered this as a suspicion, not evidence. She also said a funeral home she was told was police-accredited charged 40,000 pesos but gave a 35,000-peso receipt, which she was told was "for the boys," but she has no proof that any money reached officers. The commission says nothing presented at the hearing showed a quota or reward played a part in these deaths, calls for an investigation, and quotes forensic pathologist Dr. Raquel Fortun as saying the death certificates were deficient and the scene photos poor. The release places the account alongside earlier testimony and reporting on police rewards and quotas, and notes that ICC judges confirmed charges against Duterte in April, which he denies.

Grillo: U.S. Military Drug War in Latin America Expected to Continue Despite Midterm Losses. Ioan Grillo writes in a November 10 CrashOut Media analysis that the administration's military-first approach to drugs, which he calls the "Donroe Drug War," appears set to continue, noting that Stephen Miller was reportedly promoted to White House chief of staff after the midterms. Grillo counts more than 70 boat strikes since September 2025 that have killed at least 240 people, the most recent he cites was on October 27 in the Pacific, and says US border agents seized about 3 percent less cocaine in fiscal year 2026 than the year before. Grillo, a veteran observer of the Latin American drug trade, predicts more joint operations in Colombia, Venezuela and Ecuador and expects the administration to be more cautious about boat strikes, in part because a Democratic congressional majority may scrutinize them, and he cites a Washington Office on Latin America report calling the strikes extrajudicial killings under international human rights law. The piece is analysis, and the figures and predictions are Grillo's.

Dahas: Nine Drug-Related Killings in October, the Fewest in a Month Since Marcos Took Office. The Dahas Project at the University of the Philippines and Ghent University counted nine drug-related killings in the Philippines in October, the lowest monthly total since Ferdinand Marcos Jr. took office, it said in an X post. It listed the victims as four alleged pushers, three people with prior drug records, and two users. It said unidentified assailants killed four, state agents three, and non-state agents two. That brings the project's January-to-October 2026 count to 196, after monthly totals of 25, 19, 15, 35, 16, 23, 20, 19 and 15.

For November 1-7, Dahas reported one death in Davao de Oro; police reportedly said the man fired at them. The death brought its total for the Marcos government to 1,342, including 64 in the current fifth year. Separately, Dahas's Sandatahang Dahas tally covers violence by and against public security personnel, including clashes with alleged insurgents and protest injuries. This separate series recorded 20 killed and 103 injured in October, for 317 killed and 621 injured so far in 2026.

Harm Reduction

Fiji Readies First Needle and Syringe Program Amid HIV Emergency. Fiji's parliament passed an amendment to its HIV/AIDS Act on October 1 that lets the Health Minister authorize distribution of sterile injecting equipment, Ryan Hesketh reports in TalkingDrugs. The amendment provides for commencement on a date or dates appointed by the minister in a Gazette notice. It would make Fiji the second Pacific island nation, after Papua New Guinea, to run a formal needle and syringe program. The move comes as Fiji reported 2,016 new HIV diagnoses in 2025, the highest annual total, and more than 42 percent of cases with a known transmission route were linked to injecting drug use, primarily methamphetamine. The Health Ministry estimates that about one in 60 adults is living with HIV. Hesketh cites "sources close to the program" as saying some equipment is already being distributed unofficially. The official rollout had not begun when the article was published November 10.

Report: London Police Press Conference Helped Turn Opinion Against Canada's First Safe Supply Program. Based on documents obtained through freedom of information requests, Euan Thomson reports in Drug Data Decoded that London, Ontario police presented a July 2024 drug bust that included 11,232 prescribed hydromorphone pills alongside 2,000 grams of fentanyl as evidence of safe supply diversion linked to gun violence, but failed to produce evidence tracing the pills to the London InterCommunity Health Centre program. The article says a health unit briefing note a month later undercut that framing, and that in November 2024 the police chief told a federal committee the city's illegal drug trade was rooted in "the safe supply program." Thomson reports that federal funding for 29 safer-supply projects ended by March 2025 and that the London program closed in July 2025.

Philadelphia Jails Drop Monthly Buprenorphine Shot for Cheaper Daily Pill. Aubrey Whelan, Samantha Melamed and Jillian Kramer report for The Philadelphia Inquirer that the city's jails stopped offering Brixadi, a monthly injectable buprenorphine, in June and moved patients to daily Suboxone. Officials cite cost: Suboxone costs about $50 per patient per month compared with $1,776 a month for Brixadi after the first month. About 563 patients had received the injection since a November 2024 pilot, and an unnamed source familiar with the program estimated it cut diversion by at least 30 percent. But city officials say one in three of the 719 people prescribed Suboxone in jails since June has been caught misusing it and cut off from treatment. Prisons Commissioner Michael Resnick said, "I don't know how you divert a shot," and the city is exploring a release-day injection. The city cut jail addiction-treatment funding by more than half, to about $2 million, in June, and advocates say the change undercuts efforts to reduce overdose deaths among people leaving jail.

Psychedelics

DEA Proposes Higher 2027 Production Quotas for MDMA, Ibogaine and Psilocybin. DEA's proposed 2027 production quotas (Docket DEA-1730P) would raise MDMA to 33,296 grams from the 12,000 grams established in January for 2026, and ibogaine to 12,002 grams from 210. Psilocybin would rise to 60,000 grams from 50,000, and psilocin, listed as psilocyn, to 93,600 grams from 80,000. DEA cites increased research and clinical trials for the MDMA and ibogaine increases; production quotas do not approve treatments. The proposal also lists 6,675,000 grams of Schedule I marijuana, 1,000,000 grams of marijuana extract and 1,523,040 grams of delta-9 THC. DEA says Schedule III marijuana quotas will appear in a separate notice. The notice was published November 10; comments are due December 10.

Senate appropriations report language on VA psychedelic research is covered under Medical Marijuana.

(AI technology assisted in the news gathering and initial stage drafting of this Daily Digest.)

Add new comment

The content of this field is kept private and will not be shown publicly.